These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21521860)

  • 41. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Switch From Originator to Equivalent Drug in the Era of Generic Antiepileptic Drugs: Study of Keppra Versus Epitiram Clinical Equivalence.
    Fanella M; Morano A; Fattouch J; Albini M; Basili LM; Casciato S; Manfredi M; Giallonardo AT; Di Bonaventura C
    Clin Neuropharmacol; 2017; 40(6):239-242. PubMed ID: 28976412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of switching from Depakene to generic valproic acid on individuals with mental retardation.
    Vadney VJ; Kraushaar KW
    Ment Retard; 1997 Dec; 35(6):468-72. PubMed ID: 9425876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levetiracetam induced interstitial nephritis and renal failure.
    Hurwitz KA; Ingulli EG; Krous HF
    Pediatr Neurol; 2009 Jul; 41(1):57-8. PubMed ID: 19520278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of levetiracetam on intractable secondarily generalized seizure and depression].
    Hayashi T; Inoue K; Shinoda J
    Brain Nerve; 2012 Mar; 64(3):303-7. PubMed ID: 22402725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R; Straetemans R; Sehgal G; Stockis A; Lu ZS
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The SKATE study: interim analysis.
    Olwen GO
    Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G; Gomceli YB; Unal Y; Inan LE
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term experience with levetiracetam.
    Abou-Khalil B; Lazenby B
    Epileptic Disord; 2003 May; 5 Suppl 1():S33-7. PubMed ID: 12915339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of intravenous levetiracetam for management of acute seizures in neonates.
    Khan O; Chang E; Cipriani C; Wright C; Crisp E; Kirmani B
    Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.
    Zesiewicz TA; Louis ED; Sullivan KL; Menkin M; Dunne PB; Hauser RA
    Mov Disord; 2004 Dec; 19(12):1518-21. PubMed ID: 15390069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic equivalency of generic antiepileptic drugs: results of a survey.
    Wilner AN
    Epilepsy Behav; 2004 Dec; 5(6):995-8. PubMed ID: 15582850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased levetiracetam clearance in pregnancy: is seizure frequency affected?
    Hoeritzauer I; Mawhinney E; Irwin B; Hunt SJ; Morrow J; Craig J
    Seizure; 2012 Sep; 21(7):559-60. PubMed ID: 22658454
    [No Abstract]   [Full Text] [Related]  

  • 59. Skin rash following levetiracetam.
    Bhoi SK; Kalita J; Misra UK
    Seizure; 2016 Apr; 37():45-7. PubMed ID: 26987035
    [No Abstract]   [Full Text] [Related]  

  • 60. Response to "Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison".
    Lin Z; Xiaoyi Z
    Seizure; 2016 Oct; 41():184-6. PubMed ID: 27554810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.